Thomas Rowe

10.3k total citations · 3 hit papers
77 papers, 6.5k citations indexed

About

Thomas Rowe is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Thomas Rowe has authored 77 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 29 papers in Infectious Diseases and 19 papers in Immunology. Recurrent topics in Thomas Rowe's work include Influenza Virus Research Studies (41 papers), Respiratory viral infections research (16 papers) and Animal Disease Management and Epidemiology (16 papers). Thomas Rowe is often cited by papers focused on Influenza Virus Research Studies (41 papers), Respiratory viral infections research (16 papers) and Animal Disease Management and Epidemiology (16 papers). Thomas Rowe collaborates with scholars based in United States, Canada and China. Thomas Rowe's co-authors include Jacqueline M. Katz, Nancy J. Cox, Keiji Fukuda, Wilina Lim, Xiuhua Lu, Jean Hu‐Primmer, Mark Wolff, David E. Swayne, James D. Campbell and John J. Treanor and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas Rowe

75 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of an Avian Influenza A (H5N1) Virus Isolated from a Child with a Fatal Respiratory Illness

1998 1.1k citations Kanta Subbarao, Jacqueline M. Katz et al. profile →
Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays

1999 697 citations Thomas Rowe, Jean Hu‐Primmer et al. profile →
Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine

2006 562 citations John J. Treanor, James D. Campbell et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Thomas Rowe

Since Specialization

Citations

This map shows the geographic impact of Thomas Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Rowe more than expected).

Fields of papers citing papers by Thomas Rowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Rowe. The network helps show where Thomas Rowe may publish in the future.

Co-authorship network of co-authors of Thomas Rowe

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Rowe. A scholar is included among the top collaborators of Thomas Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Rowe. Thomas Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	On the synthesis of potassium sodium niobate, I: synthesis and crystal structure of KNaCO3 2025 ·Journal of Materials Science ·Jennifer S. Forrester, Thomas Rowe, (unknown), Paul A. Maggard, Jacob L. Jones	2
2	On the synthesis of potassium sodium niobate, II: the use of KNaCO3 to synthesize more compositionally homogeneous materials and at lower temperatures 2025 ·Journal of Materials Science ·Thomas Rowe, Jennifer S. Forrester, Jacob L. Jones	0
3	Interferon as an immunoadjuvant to enhance antibodies following influenza B infection and vaccination in ferrets 2024 ·npj Vaccines ·Thomas Rowe, Ashley A. Fletcher, Pavel Svoboda, Jan Pohl, Yasuko Hatta, Gabriela Jasso, David E. Wentworth, Ted M. Ross	0
4	Ferrets as a model for tuberculosis transmission 2022 ·Frontiers in Cellular and Infection Microbiology ·(unknown), Naveen K Somanna, Thomas Rowe, (unknown), (unknown), Simon O. Owino, (unknown), Stephen B. Harvey, (unknown), (unknown), Kaori Sakamoto, Cheryl L. Day, Christopher C. Whalen, Russell K. Karls, Biao He, S. Mark Tompkins, Abhijeet Bakre, Ted M. Ross, Frederick D. Quinn	4
5	Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution 2020 ·eLife ·John Huddleston, John Barnes, Thomas Rowe, Xiyan Xu, Rebecca Kondor, David E. Wentworth, Lynne Whittaker, Burcu Ermetal, Rodney S. Daniels, John W. McCauley, Seiichiro Fujisaki, Kazuya Nakamura, Noriko Kishida, Shinji Watanabe, Hideki Hasegawa, Ian Barr, Kanta Subbarao, Pierre Barrat-Charlaix, Richard A. Neher, Trevor Bedford	40
6	Evolution and rapid spread of a reassortant A(H3N2) virus that predominated the 2017–2018 influenza season 2019 ·Virus Evolution ·Barney Potter, Rebecca Kondor, James Hadfield, John Huddleston, John Barnes, Thomas Rowe, Lizheng Guo, Xiyan Xu, Richard A. Neher, Trevor Bedford, David E. Wentworth	24
7	Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants 2017 ·The Journal of Infectious Diseases ·Feng Liu, Vic Veguilla, F. Liaini Gross, Eric P. Gillis, Thomas Rowe, Xiyan Xu, Terrence M. Tumpey, Jacqueline M. Katz, Min Z. Levine, Xiuhua Lu	7
8	CXCL14 deficiency does not impact the outcome of influenza or Escherichia coli infections in mice 2014 ·The Journal of Infection in Developing Countries ·(unknown), Alberto J. León, David W. Banner, Alyson A. Kelvin, Thomas Rowe, Ivo Boudakov, (unknown), Barry B. Rubin, David J. Kelvin	5
9	Lack of Innate Interferon Responses during SARS Coronavirus Infection in a Vaccination and Reinfection Ferret Model 2012 ·PLoS ONE ·Mark J. Cameron, Alyson A. Kelvin, Alberto J. León, Cheryl Cameron, Longsi Ran, Luoling Xu, Yong-Kyu Chu, Ali Danesh, Fang Yuan, Qianjun Li, (unknown), Ronald C. Couch, Stéphane G. Paquette, N.G. Fomukong, Otfried Kistner, (unknown), Thomas Rowe, Kevin S. Harrod, Colleen B. Jonsson, David J. Kelvin	54
10	Seroprevalence of Antibodies to Avian Influenza A (H5) and A (H9) Viruses among Market Poultry Workers, Hanoi, Vietnam, 2001 2012 ·PLoS ONE ·Timothy M. Uyeki, Doan C. Nguyen, Thomas Rowe, Xiuhua Lu, Jean Hu‐Primmer, (unknown), Nguyễn Lê Khánh Hằng, Jacqueline M. Katz	63
11	Cloning, expression and immunoassay detection of ferret IFN-γ 2008 ·Developmental & Comparative Immunology ·Atsuo Ochi, Ali Danesh, Charit Seneviratne, David W. Banner, Mark E. DeVries, Thomas Rowe, Luoling Xu, Longsi Ran, Markus Czub, Steven E. Bosinger, Mark J. Cameron, Cheryl Cameron, David J. Kelvin	22
12	Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine breakdown → 2006 ·New England Journal of Medicine ·John J. Treanor, James D. Campbell, Kenneth M. Zangwill, Thomas Rowe, Mark Wolff	562
13	Neurological Manifestations of Avian Influenza Viruses in Mammals 2003 ·Avian Diseases ·Thomas Rowe, (unknown), Rick A. Bright, Lois A. Zitzow, Jacqueline M. Katz	23
14	Risk of Influenza A (H5N1) Infection among Poultry Workers, Hong Kong, 1997–1998 2002 ·The Journal of Infectious Diseases ·Carolyn B. Bridges, Wilina Lim, Jean Hu‐Primmer, (unknown), Keiji Fukuda, Kwok Hang Mak, Thomas Rowe, W. Thompson, Laura A. Conn, Xiuhua Lu, Nancy J. Cox, Jacqueline M. Katz	205
15	Influenza Virus–Stimulated Generation of Anti–Human Immunodeficiency Virus (HIV) Activity after Influenza Vaccination in HIV‐Infected Individuals and Healthy Control Subjects 2001 ·The Journal of Infectious Diseases ·Lígia A. Pinto, Vesna Blazevic, Stephanie A. Anderson, David Venzon, Charles M. Trubey, Thomas Rowe, Jacqueline M. Katz, David J. Liewehr, Matthew J. Dolan, Gene M. Shearer	15
16	Chronic immune stimulation accelerates SIV‐induced disease progression 2001 ·Journal of Medical Primatology ·(unknown), Thomas Rowe, Bharat Parekh, Timothy A. Green, Ann E. Mayne, Bennett D. Grimm, Harold M. McClure, Andrew A. Lackner, Peter J. Dailey, Aftab A. Ansari, Thomas M. Folks	24
17	Massive Intracranial Immature Teratoma with Extracranial Extension into Oral Cavity, Nose, and Neck 1998 ·Fetal Diagnosis and Therapy ·(unknown), Karen E. Shattuck, Thomas Rowe, (unknown)	22
18	Tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 expression in human amnion mesenchymal and epithelial cells 1997 ·American Journal of Obstetrics and Gynecology ·Thomas Rowe, Lisa A. King, Paul C. MacDonald, M.Linette Casey	40
19	Infection of a Laboratory Worker with Simian Immunodeficiency Virus 1994 ·New England Journal of Medicine ·Rima Khabbaz, Walid Heneine, J. Richard George, Bharat Parekh, Thomas Rowe, Toni Woods, William M. Switzer, Harold M. McClure, Michael Murphey‐Corb, Thomas M. Folks	91
20	Simian immunodeficiency virus needlestick accident in a laboratory worker 1992 ·The Lancet ·Rima Khabbaz, Thomas Rowe, Walid Heneine, J E Kaplan, T M Folks, Charles A. Schable, J. Richard George, Chou‐Pong Pau, Bharat Parekh, James W. Curran, Gerald Schochetman, Michael D. Lairmore, Michael Murphey‐Corb	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact